- Home
- KOD vs CLBR Comparison
KOD vs CLBR Comparison
Compare KOD & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- CLBR
- Stock Information
- Founded
- KOD 2009
- CLBR 2023
- Country
- KOD United States
- CLBR United States
- Employees
- KOD N/A
- CLBR N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- CLBR
- Sector
- KOD Health Care
- CLBR
- Exchange
- KOD Nasdaq
- CLBR Nasdaq
- Market Cap
- KOD 186.3M
- CLBR 219.3M
- IPO Year
- KOD 2018
- CLBR 2023
- Fundamental
- Price
- KOD $5.33
- CLBR $10.53
- Analyst Decision
- KOD Hold
- CLBR
- Analyst Count
- KOD 5
- CLBR 0
- Target Price
- KOD $3.25
- CLBR N/A
- AVG Volume (30 Days)
- KOD 395.9K
- CLBR 183.9K
- Earning Date
- KOD 11-26-2024
- CLBR 01-01-0001
- Dividend Yield
- KOD N/A
- CLBR N/A
- EPS Growth
- KOD N/A
- CLBR N/A
- EPS
- KOD N/A
- CLBR N/A
- Revenue
- KOD N/A
- CLBR N/A
- Revenue This Year
- KOD N/A
- CLBR N/A
- Revenue Next Year
- KOD N/A
- CLBR N/A
- P/E Ratio
- KOD N/A
- CLBR $135.22
- Revenue Growth
- KOD N/A
- CLBR N/A
- 52 Week Low
- KOD $1.90
- CLBR $9.16
- 52 Week High
- KOD $7.77
- CLBR $10.55
- Technical
- Relative Strength Index (RSI)
- KOD 76.60
- CLBR 82.53
- Support Level
- KOD $3.73
- CLBR $10.31
- Resistance Level
- KOD $5.58
- CLBR $10.35
- Average True Range (ATR)
- KOD 0.28
- CLBR 0.03
- MACD
- KOD 0.11
- CLBR 0.02
- Stochastic Oscillator
- KOD 88.02
- CLBR 89.29
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.